Effexor and Neurosensory hypoacusis - a phase IV clinical study of FDA data
Neurosensory hypoacusis is reported only by a few people who take Effexor.
The phase IV clinical study analyzes which people take Effexor and have Neurosensory hypoacusis. It is created by eHealthMe based on reports of 88,368 people who have side effects while taking Effexor from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
88,368 people reported to have side effects when taking Effexor.
Among them, 2 people (0.0%) have Neurosensory hypoacusis.
What is Effexor?
Effexor has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 95,239 Effexor users for its effectiveness, alternative drugs and more.
What is Neurosensory hypoacusis?
Neurosensory hypoacusis (a type of hearing loss in which the root cause lies in the vestibulocochlear nerve) is found to be associated with 113 drugs and 43 conditions by eHealthMe.
Number of Effexor and Neurosensory hypoacusis reports submitted per year:
Gender of people who have Neurosensory hypoacusis when taking Effexor *:
- female: 100 %
- male: 0.0 %
Age of people who have Neurosensory hypoacusis when taking Effexor *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Common drugs people take besides Effexor *:
- Rythmol: 2 people, 100.00%
- Pravastatin Sodium: 2 people, 100.00%
- Nulytely: 2 people, 100.00%
- Memantine: 2 people, 100.00%
Common side effects people have besides Neurosensory hypoacusis *:
- Orthostatic Hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up): 2 people, 100.00%
- Dizziness: 2 people, 100.00%
- Memory Loss: 1 person, 50.00%
- Confusion: 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Effexor and have Neurosensory hypoacusis?Check whether Neurosensory hypoacusis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Neurosensory hypoacusis and when was it recovered:
Expand to all the drugs that have ingredients of venlafaxine hydrochloride:
Alternative drugs to, pros and cons of Effexor:
- Effexor (95,239 reports)
Common Effexor side effects:
Browse all side effects of Effexor:a b c d e f g h i j k l m n o p q r s t u v w x y z
Neurosensory hypoacusis treatments and more:
- Neurosensory hypoacusis (132 reports)
COVID vaccines that are related to Neurosensory hypoacusis:
- Neurosensory hypoacusis in Moderna COVID Vaccine
- Neurosensory hypoacusis in Pfizer BioNTech Covid Vaccine
- Neurosensory hypoacusis in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Neurosensory hypoacusis:
- Neurosensory hypoacusis (113 drugs)
All the conditions that are associated with Neurosensory hypoacusis:
- Neurosensory hypoacusis (43 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on venlafaxine hydrochloride (the active ingredients of Effexor) and Effexor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lucentis and Bactrim Ds drug interaction - 12 seconds ago
- Vytorin and Hair Growth Abnormal - 18 seconds ago
- Moduretic 5-50 and Haldol drug interaction - 32 seconds ago
- Irinotecan Hydrochloride and Ifosfamide drug interaction - 32 seconds ago
- Fluconazole and Gallbladder Perforation - 44 seconds ago
- Lopid and Muscle Tightness - 47 seconds ago
- Hyperkalemia and Bladder Cancer - 47 seconds ago
- Omega-3 Marine Triglycerides and Benazepril Hydrochloride drug interaction - 53 seconds ago
- Actiq and Irritable Bowel Syndrome - 53 seconds ago
- Baclofen and Faecal Volume Increased - 59 seconds ago